Compare NPCE & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPCE | GCO |
|---|---|---|
| Founded | 1997 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.2M | 421.8M |
| IPO Year | 2021 | 1994 |
| Metric | NPCE | GCO |
|---|---|---|
| Price | $14.15 | $33.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $18.33 | ★ $33.00 |
| AVG Volume (30 Days) | 104.7K | ★ 214.8K |
| Earning Date | 05-12-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.03 | ★ 171.84 |
| EPS | ★ N/A | N/A |
| Revenue | $99,986,000.00 | ★ $2,606,898,000.00 |
| Revenue This Year | $0.90 | $0.78 |
| Revenue Next Year | $24.46 | $2.12 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.13 | 13.71 |
| 52 Week Low | $9.22 | $21.93 |
| 52 Week High | $19.60 | $43.60 |
| Indicator | NPCE | GCO |
|---|---|---|
| Relative Strength Index (RSI) | 46.56 | 46.97 |
| Support Level | $13.75 | $31.67 |
| Resistance Level | $15.33 | $36.70 |
| Average True Range (ATR) | 0.55 | 1.53 |
| MACD | -0.01 | 0.13 |
| Stochastic Oscillator | 27.12 | 40.97 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Genesco Inc sells footwear, headwear, sports apparel, and accessories. It has four reportable business segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass. The brands of the company are: Journeys; Journeys Kidz; Little Burgundy; Schuh; Johnston & Murphy; and Genesco Brands Group.